Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

NCT01207102 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Low enrollment and there is insufficient data to publish.

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Abraxane
DRUG: Carboplatin

Sponsor

Duke University

Collaborators

[object Object]